Signaling Proteins and Transcription Factors in Normal and Malignant Early B Cell Development

Abstract EN

B cell development starts in bone marrow with the commitment of hematopoietic progenitors to the B cell lineage.

In murine models, the IL-7 and preBCR receptors, and the signaling pathways and transcription factors that they regulate, control commitment and maintenance along the B cell pathway.

E2A, EBF1, PAX5, and Ikaros are among the most important transcription factors controlling early development and thereby conditioning mice homeostatic B cell lymphopoiesis.

Importantly, their gain or loss of function often results in malignant development in humans, supporting conserved roles for these transcription factors.

B cell acute lymphoblastic leukemia is the most common cause of pediatric cancer, and it is characterized by unpaired early B cell development resulting from genetic lesions in these critical signaling pathways and transcription factors.

Fine mapping of these genetic abnormalities is allowing more specific treatments, more accurately predicting risk profiles for this disease, and improving survival rates.